Stay updated with breaking news from Afmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Affimed (NASDAQ:AFMD – Get Rating) in a research note released on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Other analysts have also issued reports about the company. Wells Fargo & Company reiterated an overweight rating and set a $7.00 price target on shares of […]
Research analysts at StockNews.com started coverage on shares of Affimed (NASDAQ:AFMD – Get Rating) in a research note issued to investors on Thursday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Several other analysts have also recently commented on AFMD. Stifel Nicolaus reduced their price target on Affimed from $2.00 to $1.00 […]
Affimed (NASDAQ:AFMD – Get Rating) is scheduled to post its quarterly earnings results before the market opens on Tuesday, May 23rd. Analysts expect Affimed to post earnings of ($0.22) per share for the quarter. Affimed (NASDAQ:AFMD – Get Rating) last posted its quarterly earnings results on Thursday, March 23rd. The biopharmaceutical company reported ($0.22) earnings […]
Shares of Affimed (NASDAQ:AFMD – Get Rating) have been assigned an average rating of “Moderate Buy” from the eight analysts that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating on the […]
Affimed (NASDAQ:AFMD – Get Rating) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 5,830,000 shares, a growth of 9.2% from the March 31st total of 5,340,000 shares. Based on an average trading volume of 1,010,000 shares, the days-to-cover ratio […]